More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition, […]
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition,
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition,
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition,
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition,
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition,
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition,
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition,
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition,
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.However, fewer than one in five received medication to treat this condition. In addition, the
